Cytokine network involvement in subjects exposed to benzene

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Minciullo, Paola Lucia ^a   Navarra, Michele ^b   Calapai, Gioacchino ^a   Gangemi, Sebastiano ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CYTOKINE; POLLUTANT;

ATOPY; BLOOD TOXICITY; ENVIRONMENTAL EXPOSURE; HUMAN; LUNG TOXICITY; REVIEW; ADVERSE EFFECTS; BLOOD; DRUG EFFECTS; HEMATOPOIESIS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; POLLUTANT; SIGNAL TRANSDUCTION; TOXICITY;

BENZENE; CYTOKINES; ENVIRONMENTAL POLLUTANTS; HEMATOPOIESIS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LUNG; SIGNAL TRANSDUCTION;

EID: 84907417877     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/937987     Document Type: Review

References (42)

1. S.M. Arnold, J. Angerer, P. J. Boogaard et al., "The use of biomonitoring data in exposure and human health risk assessment: benzene case study," Critical Reviews in Toxicology, vol. 43, no. 2, pp. 119-153, 2013.
2. S. Wilbur, D. Wohlers, S. Paikoff, L. S. Keith, and O. Faroon, "ATSDR evaluation of potential for human exposure to benzene," Toxicology and Industrial Health, vol. 24,no. 5-6, pp. 399-442, 2008.
3. A. Fahy, G. Lethbridge, R. Earle, A. S. Ball, K. N. Timmis, and T. J. McGenity, "Effects of long-term benzene pollution on bacterial diversity and community structure in groundwater," Environmental Microbiology, vol. 7, no. 8, pp. 1192-1199, 2005.
4. H. B. Kerfoot, W. D. Brady, W. H. Schramm, and M. A. Allendorf, "Natural gas as the source of benzene in groundwater," Environmental Forensics, vol. 10, no. 1, pp. 60-67, 2009.
5. R. Snyder, G. Witz, and B. D. Goldstein, "The toxicology of benzene," Environmental Health Perspectives, vol. 100, pp. 293-306, 1993.
6. D. E. Rickert, T. S. Baker, J. S. Bus, C. S. Barrow, and R. D. Irons, "Benzene disposition in the rat after exposure by inhalation," Toxicology and Applied Pharmacology, vol. 49, no. 3, pp. 417-423, 1979.
7. IARC, "Some industrial chemicals and dyestuffs," IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 29, pp. 1-398, 1982.
8. R. Baan, Y. Grosse, K. Straif, and et al, "A review of human carcinogens. Part F. chemical agents and related occupations," The Lancet Oncology, vol. 10, no. 12, pp. 1143-1144, 2009.
9. C.M. Mchale, L. Zhang, and M. T. Smith, "Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment," Carcinogenesis, vol. 33, no. 2, pp. 240-252, 2012.
10. IPCS, "Benzene," International Programme on Chemical Safety (Environmental Health Criteria 150), World Health Organization, Geneva, Switzerland, 1993, http://www.inchem.org/documents/ehc/ehc/ehc150.htm.
11. A. R. Schnatter, D. C. Glass, G. Tang, R. D. Irons, and L. Rushton, "Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis," Journal of the National Cancer Institute, vol. 104, no. 22, pp. 1724-1737, 2012.
12. ATSDR, "Toxicological profile for benzene," 2007, http://www.atsdr.cdc.gov/toxprofiles/tp3.pdf.
13. O. N. Donkor, M. Ravikumar, O. Proudfoot et al., "Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure," Clinical and Experimental Immunology, vol. 167, no. 2, pp. 282-295, 2012.
14. G. F. Kalf, J. F. Renz, and R. Niculescu, "p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins- 1α and -1β to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1β converting enzyme," Environmental Health Perspectives, vol. 104, supplement 6, pp. 1251-1256, 1996.
15. A. G. King, K. S. Landreth, and D. Wierda, "Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation," Journal of Pharmacology and Experimental Therapeutics, vol. 250, no. 2, pp. 582-590, 1989.
16. A. C. K. Miller, D. G. Schattenberg, A. M. Malkinson, and D. Ross, "Decreased content of the IL1α processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone," Toxicology Letters, vol. 74, no. 2, pp. 177-184, 1994.
17. D. Ross, D. Siegel, D. G. Schattenberg, X. M. Sun, and J. L. Moran, "Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: Identification of target cells and a potential role for modulation of apoptosis in benzene toxicity," Environmental Health Perspectives, vol. 104, no. 6, pp. 1177-1182, 1996.
18. G. F. Kalf, "Utility of a mouse model for studying the effects of benzene on the myeloid lineage: effects of hydroquinone on a model myeloid system," Journal of Toxicology and Environmental Health A, vol. 61, no. 5-6, pp. 399-411, 2000.
19. Q. Lan, L. Zhang, M. Shen et al., "Polymorphisms in cytokine and cellular adhesion molecule gene and susceptibility to hematotoxicity among workers exposed to benzene," Cancer Research, vol. 65, no. 20, pp. 9574-9581, 2005.
20. L. Zhang, C. M. McHale, N. Rothman et al., "Systems biology of human benzene exposure," Chemico-Biological Interactions, vol. 184, no. 1-2, pp. 86-93, 2010.
21. B. Gillis, I.M. Gavin, Z. Arbieva, S.T. King, S. Jayaraman, and B. S. Prabhakar, "Identification of human cell responses to benzene and benzenemetabolites," Genomics, vol. 90, no. 3, pp. 324-333, 2007.
22. J. F. Renz and G. F. Kalf, "Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1α to mature cytokine inmurine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1α," Blood, vol. 78, no. 4, pp. 938-944, 1991.
23. P. Carbonnelle, D. Lison, J. Y. Leroy, and R. Lauwerys, "Effect of the benzene metabolite, hydroquinone, on interleukin-1 secretion by human monocytes in vitro," Toxicology and Applied Pharmacology, vol. 132, no. 2, pp. 220-226, 1995.
24. R. Niculescu, H. N. Bradford, R. W. Colman, and G. F. Kalf, "Inhibition of the conversion of pre-interleukins-1α and 1β to mature cytokines by p-benzoquinone, ametabolite of benzene," Chemico-Biological Interactions, vol. 98, no. 3, pp. 211-222, 1995.
25. R. D. Irons and W. S. Stillman, "Impact of benzene metabolites on differentiation of bone marrow progenitor cells," Environmental Health Perspectives, vol. 104, no. 6, pp. 1247-1250, 1996.
26. P. J. Kerzic, D.W. Pyatt, J. H. Zheng, S. A. Gross, A. Le, and R. D. Irons, "Inhibition of NF-κB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-α-induced apoptosis," Toxicology, vol. 187, no. 2-3, pp. 127-137, 2003.
27. L. Lv, P. Kerzic, G. Lin et al., "The TNF-α 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene," Leukemia Research, vol. 31, no. 11, pp. 1479-1485, 2007.
28. N. Rothman, M. T. Smith, R. B. Hayes et al., "An epidemiologic study of early biologic effects of benzene in Chinese workers," Environmental Health Perspectives, vol. 104, supplement 6, pp. 1365-1370, 1996.
29. L. C. Haro-García, C. A. Juárez-Pérez, G. Aguilar-Madrid et al., "Production of IL-10, TNF and IL-12 by peripheral blood mononuclear cells in Mexican workers exposed to a mixture of benzene-toluene-xylene," Archives of Medical Research, vol. 43, no. 1, pp. 51-57, 2012.
30. G. Spatari, S. Saitta,C.Giorgianni et al., "Interleukin-10 involvement in exposure to low dose of benzene," Toxicology and Industrial Health, 2013.
31. R. Vermeulen, Q. Lan, L. Zhang et al., "Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 47, pp. 17041-17046, 2005.
32. S.Méndez-Ferrer, T. V.Michurina, F. Ferraro et al., "Mesenchymal and haematopoietic stem cells forma unique bone marrow niche," Nature, vol. 466, no. 7308, pp. 829-834, 2010.
33. Y. Omatsu, T. Sugiyama, H. Kohara et al., "The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche," Immunity, vol. 33, no. 3, pp. 387-399, 2010.
34. F. Zolghadr, M. Sadeghizadeh, N. Amirizadeh, S. Hosseinkhani, and S. Nazem, "How benzene and its metabolites affect human marrow derived mesenchymal stem cells," Toxicology Letters, vol. 214, no. 2, pp. 145-153, 2012.
35. D. Bironaite, D. Siegel, J. L. Moran, B. B. Weksler, and D. Ross, "Stimulation of endothelial IL-8 (eIL-8) production and apoptosis by phenolic metabolites of benzene in HL-60 cells and human bone marrow endothelial cells," Chemico-Biological Interactions, vol. 149, no. 2-3, pp. 177-188, 2004.
36. M. Miyazawa, Y. Ito, Y. Yoshida, H. Sakaguchi, and H. Suzuki, "Phenotypic alterations and cytokine production in THP-1 cells in response to allergens," Toxicology in Vitro, vol. 21, no. 3, pp. 428-437, 2007.
37. +hematopoietic cell adhesion," Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 1, pp. 260-268, 2010.
38. M. Triggiani, S. Loffredo, F. Granata, R. I. Staiano, and G. Marone, "Modulation of mast cell and basophil functions by benzene metabolites," Current Pharmaceutical Design, vol. 17, no. 34, pp. 3830-3835, 2011.
39. P. Boscolo, M. Di Gioacchino, E. Sabbioni et al., "Lymphocyte subpopulations, cytokines and trace elements in asymptomatic atopic women exposed to an urban environment," Life Sciences, vol. 67, no. 10, pp. 1119-1126, 2000.
40. I. Lehmann, M. Rehwagen, U. Diez et al., "Enhanced in vivo IgE production and T cell polarization toward the type 2 phenotype in association with indoor exposure to VOC: results of the LARS study," International Journal of Hygiene and Environmental Health, vol. 204, no. 4, pp. 211-221, 2001.
41. Q. Li, L. Geiselhart, J. N. Mittler, S. P. Mudzinski, D. A. Lawrence, and B. M. Freed, "Inhibition of human T lymphoblast proliferation by hydroquinone," Toxicology and Applied Pharmacology, vol. 139, no. 2, pp. 317-323, 1996.
42. S. Aggarwal, A. A. van de Loosdrecht, C. Alhan, G. J. Ossenkoppele, T. M. Westers, and H. J. Bontkes, "Role of immune responses in the pathogenesis of low-risk MDS and highrisk MDS: implications for immunotherapy," British Journal of Haematology, vol. 153, no. 5, pp. 568-581, 2011.